Free Trial

Groupama Asset Managment Sells 3,238 Shares of AMETEK, Inc. (NYSE:AME)

AMETEK logo with Computer and Technology background
Remove Ads

Groupama Asset Managment trimmed its position in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 10.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,135 shares of the technology company's stock after selling 3,238 shares during the quarter. Groupama Asset Managment's holdings in AMETEK were worth $5,085,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of the business. Norges Bank acquired a new position in AMETEK in the fourth quarter valued at approximately $697,080,000. EdgePoint Investment Group Inc. raised its position in shares of AMETEK by 87.9% during the third quarter. EdgePoint Investment Group Inc. now owns 1,964,236 shares of the technology company's stock worth $337,279,000 after purchasing an additional 918,737 shares during the period. American Century Companies Inc. lifted its stake in AMETEK by 240.3% in the fourth quarter. American Century Companies Inc. now owns 1,125,068 shares of the technology company's stock valued at $202,805,000 after buying an additional 794,473 shares in the last quarter. Principal Financial Group Inc. boosted its stake in AMETEK by 72.0% in the 3rd quarter. Principal Financial Group Inc. now owns 1,680,309 shares of the technology company's stock worth $288,526,000 after purchasing an additional 703,501 shares during the period. Finally, Bryn Mawr Capital Management LLC boosted its position in shares of AMETEK by 10,506.5% during the fourth quarter. Bryn Mawr Capital Management LLC now owns 476,442 shares of the technology company's stock worth $812,000 after buying an additional 471,950 shares during the period. 87.43% of the stock is currently owned by institutional investors.

Remove Ads

AMETEK Stock Down 6.6 %

Shares of AMETEK stock traded down $11.38 on Thursday, hitting $161.34. The company had a trading volume of 1,872,974 shares, compared to its average volume of 1,238,966. The stock has a market capitalization of $37.23 billion, a price-to-earnings ratio of 27.21, a P/E/G ratio of 2.73 and a beta of 1.14. The stock has a 50 day moving average of $181.27 and a 200-day moving average of $180.90. AMETEK, Inc. has a 1 year low of $149.03 and a 1 year high of $198.33. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.75 and a current ratio of 1.24.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.87 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.02. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.82 billion. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. The firm's quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.68 EPS. As a group, sell-side analysts forecast that AMETEK, Inc. will post 7.15 earnings per share for the current year.

AMETEK Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Friday, March 14th were given a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, March 14th. This is a positive change from AMETEK's previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 0.77%. AMETEK's payout ratio is presently 20.91%.

AMETEK announced that its board has approved a stock repurchase program on Friday, February 7th that allows the company to buyback $1.25 billion in outstanding shares. This buyback authorization allows the technology company to buy up to 2.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on AME shares. Truist Financial raised their price target on AMETEK from $221.00 to $222.00 and gave the company a "buy" rating in a research note on Thursday, January 16th. StockNews.com raised shares of AMETEK from a "hold" rating to a "buy" rating in a research report on Thursday. Robert W. Baird dropped their target price on shares of AMETEK from $200.00 to $197.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Bank of America raised AMETEK from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $195.00 to $225.00 in a research report on Monday, December 16th. Finally, BNP Paribas upgraded AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 target price for the company in a research note on Thursday, January 16th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $204.67.

Read Our Latest Report on AME

Insider Transactions at AMETEK

In other AMETEK news, Director Thomas A. Amato sold 710 shares of the firm's stock in a transaction on Thursday, March 27th. The shares were sold at an average price of $176.64, for a total value of $125,414.40. Following the sale, the director now owns 10,560 shares of the company's stock, valued at $1,865,318.40. This trade represents a 6.30 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Steven W. Kohlhagen sold 1,320 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $189.41, for a total value of $250,021.20. Following the transaction, the director now directly owns 22,029 shares in the company, valued at $4,172,512.89. This trade represents a 5.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.57% of the stock is currently owned by insiders.

AMETEK Profile

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Further Reading

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Should You Invest $1,000 in AMETEK Right Now?

Before you consider AMETEK, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.

While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Best ETFs for Spring 2025: Strong and Steady Investing

Best ETFs for Spring 2025: Strong and Steady Investing

Whether you're after broad market exposure, dividend income, bonds, or even gold, we've got picks that can help you navigate the current investing landscape.

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Volatility-Proof Your Portfolio with These 7 ETFs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads